Amedisys, Inc.
AMED
$100.99
$0.0050.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.19% | 4.09% | 4.78% | 5.65% | 6.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.19% | 4.09% | 4.78% | 5.65% | 6.91% |
| Cost of Revenue | 6.59% | 3.89% | 7.22% | 8.32% | 9.91% |
| Gross Profit | 3.46% | 4.34% | 1.63% | 2.25% | 3.42% |
| SG&A Expenses | 0.27% | 1.47% | 1.50% | 2.77% | 1.14% |
| Depreciation & Amortization | -0.32% | 4.12% | 10.21% | 7.62% | -7.17% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.18% | 2.99% | 5.07% | 6.21% | 6.32% |
| Operating Income | 13.45% | 15.00% | 1.40% | -0.41% | 12.00% |
| Income Before Tax | -1.84% | 234.98% | -165.85% | -23.61% | 179.11% |
| Income Tax Expenses | 15.71% | 132.60% | -38.19% | 1.15% | -8.73% |
| Earnings from Continuing Operations | -10.81% | 323.61% | -234.17% | -35.53% | 140.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -255.88% | -317.01% | 1,601.32% | 15.41% | -232.04% |
| Net Income | -13.06% | 323.69% | -205.48% | -34.86% | 140.24% |
| EBIT | 13.45% | 15.00% | 1.40% | -0.41% | 12.00% |
| EBITDA | 12.72% | 14.53% | 2.83% | 1.09% | 11.08% |
| EPS Basic | -13.44% | 322.07% | -205.10% | -35.10% | 140.08% |
| Normalized Basic EPS | 21.29% | 22.66% | 32.49% | 6.09% | -4.86% |
| EPS Diluted | -14.29% | 318.18% | -206.83% | -35.44% | 139.77% |
| Normalized Diluted EPS | 20.93% | 22.23% | 33.63% | 5.50% | -5.84% |
| Average Basic Shares Outstanding | 0.44% | 0.38% | 0.36% | 0.37% | 0.39% |
| Average Diluted Shares Outstanding | 0.73% | 0.72% | -0.49% | 0.93% | 1.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |